Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP697825.RAnNg8PbVn3591RwCJnWQdRLyzGvbmnaQNDXok8cccBXE130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP697825.RAnNg8PbVn3591RwCJnWQdRLyzGvbmnaQNDXok8cccBXE130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP697825.RAnNg8PbVn3591RwCJnWQdRLyzGvbmnaQNDXok8cccBXE130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP697825.RAnNg8PbVn3591RwCJnWQdRLyzGvbmnaQNDXok8cccBXE130_provenance.
- NP697825.RAnNg8PbVn3591RwCJnWQdRLyzGvbmnaQNDXok8cccBXE130_assertion description "[Oncolytic measles virus (MV) encoding the human thyroidal sodium iodide symporter (MV-NIS) has proved to be safe after intraperitoneal or intravenous administration in patients with ovarian cancer or multiple myeloma, respectively, but it has not yet been administered through intratumoral injection in humans.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP697825.RAnNg8PbVn3591RwCJnWQdRLyzGvbmnaQNDXok8cccBXE130_provenance.
- NP697825.RAnNg8PbVn3591RwCJnWQdRLyzGvbmnaQNDXok8cccBXE130_assertion evidence source_evidence_literature NP697825.RAnNg8PbVn3591RwCJnWQdRLyzGvbmnaQNDXok8cccBXE130_provenance.
- NP697825.RAnNg8PbVn3591RwCJnWQdRLyzGvbmnaQNDXok8cccBXE130_assertion SIO_000772 22235810 NP697825.RAnNg8PbVn3591RwCJnWQdRLyzGvbmnaQNDXok8cccBXE130_provenance.
- NP697825.RAnNg8PbVn3591RwCJnWQdRLyzGvbmnaQNDXok8cccBXE130_assertion wasDerivedFrom befree-20150227 NP697825.RAnNg8PbVn3591RwCJnWQdRLyzGvbmnaQNDXok8cccBXE130_provenance.
- NP697825.RAnNg8PbVn3591RwCJnWQdRLyzGvbmnaQNDXok8cccBXE130_assertion wasGeneratedBy ECO_0000203 NP697825.RAnNg8PbVn3591RwCJnWQdRLyzGvbmnaQNDXok8cccBXE130_provenance.
- befree-20150227 importedOn "2015-02-27" NP697825.RAnNg8PbVn3591RwCJnWQdRLyzGvbmnaQNDXok8cccBXE130_provenance.